Literature DB >> 16921118

Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation.

Dwight C Look1, Cecilia L Chin, Lori J Manzel, Erin E Lehman, Alicia L Humlicek, Lei Shi, Timothy D Starner, Gerene M Denning, Timothy F Murphy, Sanjay Sethi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16921118      PMCID： PMC2647636          DOI： 10.1513/pats.200603-060MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


× No keyword cloud information.
  12 in total

1.  Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Catherine Wrona; Brydon J B Grant; Timothy F Murphy
Journal:  Am J Respir Crit Care Med       Date:  2003-11-03       Impact factor: 21.405

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.

Authors:  N Soler; S Ewig; A Torres; X Filella; J Gonzalez; A Zaubet
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

4.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.

Authors:  A T Hill; E J Campbell; S L Hill; D L Bayley; R A Stockley
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

5.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.

Authors:  N Soler; A Torres; S Ewig; J Gonzalez; R Celis; M El-Ebiary; C Hernandez; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

6.  Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis.

Authors:  V Bandi; M A Apicella; E Mason; T F Murphy; A Siddiqi; R L Atmar; S B Greenberg
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

7.  Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.

Authors:  Cecilia L Chin; Lori J Manzel; Erin E Lehman; Alicia L Humlicek; Lei Shi; Timothy D Starner; Gerene M Denning; Timothy F Murphy; Sanjay Sethi; Dwight C Look
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

Review 8.  The role of bacteria in exacerbations of COPD. A constructive view.

Authors:  T F Murphy; S Sethi; M S Niederman
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

9.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Robert L Atmar; Keith Hattotuwa; Kay K Guntupalli; Peter K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

10.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245
View more
  4 in total

1.  Fiber-optic microsphere-based antibody array for the analysis of inflammatory cytokines in saliva.

Authors:  Timothy M Blicharz; Walter L Siqueira; Eva J Helmerhorst; Frank G Oppenheim; Philip J Wexler; Frédéric F Little; David R Walt
Journal:  Anal Chem       Date:  2009-03-15       Impact factor: 6.986

2.  Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease.

Authors:  Ama-Tawiah Essilfie; Jodie L Simpson; Jay C Horvat; Julie A Preston; Margaret L Dunkley; Paul S Foster; Peter G Gibson; Philip M Hansbro
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

3.  Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD.

Authors:  Borja G Cosío; Andreas Jahn; Amanda Iglesias; Hanaa Shafiek; Xavier Busquets; Alvar Agustí
Journal:  BMC Pulm Med       Date:  2015-12-07       Impact factor: 3.317

4.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.